Cardiotoxicity of chemotherapeutic agents

$2.00

Author(s): Lanier, Gregg M.

Series: Cancer etiology diagnosis and treatments.; Cardiology research and clinical developments series.

Publisher: Nova Science Publishers, Year: 2017

ISBN: 9781536121193,1536121193

Cardiotoxicity is a well-established complication of antineoplastic agents. Cardiomyopathy resulting from anthracyclines is a classic example. In the past decade, an explosion of novel cancer therapies, often targeted and more specific than conventional therapies, has revolutionized oncology therapy and dramatically changed cancer prognosis. However, some of these therapies have introduced an assortment of cardiovascular complications. At times, these devastating outcomes have only become apparent after drug approval and have limited the use of potent therapies. There is a growing need for better testing platforms, both for cardiovascular toxicity screening and for elucidating mechanisms of cardiotoxicity of approved cancer therapies. Our book is a comprehensive summary of information of numerous antineoplastic agents and their cardiovascular adverse effects. Cardiac oncology is an exciting and ever-changing field, and we have attempted to synthesize information from all the major and

close

Stay Connected

We don’t spam! Read our privacy policy for more info.

Shopping Cart